Key facts
- It has raised $1.7M; the latest was Later Stage VC ($1.4M) in May 2025.
- Notable investors include Hard2beat, INNOventure (Poland).
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Neuromedical
- ·The full record, as it builds
Funding rounds
No funding rounds for Neuromedical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Neuromedical
Developer of an electrostimulating medical device designed for patients with mild cognitive impairment. The company's device is a non-invasive, transdermal device that stimulates the vagus nerve responsible for memory consolidation, enabling patients suffering from Alzheimer's disease to boost memory and make their lives easier.
- Sector
- Healthcare
- HQ
- Lodz, Poland
- Founded
- 2016
- Employees
- 3
- Website
- neuromedical.pl/
- Ownership
- Privately Held (backing)
Neuromedical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Neuromedical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Neuromedical in its N-PORT filings yet. We sweep new filings monthly.